BMJ Publishing Group, BMJ, 7400(326), p. 1167-1170, 2003
DOI: 10.1136/bmj.326.7400.1167
Full text: Download
Objective To investigate whether funding of drug studies by the pharmaceutical industry is associated with outcomes that are favourable to the funder and whether the methods of trials funded by pharmaceutical companies differ from the methods in trials with other sources of support.